ASH exhibits necroptosis-mediated cell death in RIPK-3-dependent and RIPK-1-independent manner [57], whereas RIPK-3 seems not to participate in NASH development [58], even though the role of RIPKs is still controversial [42,46,59]. The gene discussed is RIPK3; the disease is metabolic dysfunction-associated steatohepatitis.